tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Ishihara Sangyo Kaisha Reports Robust Q1 Financial Performance

Story Highlights
Ishihara Sangyo Kaisha Reports Robust Q1 Financial Performance

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

ISHIHARA SANGYO KAISHA, LTD. ( (JP:4028) ) has shared an announcement.

Ishihara Sangyo Kaisha, Ltd. reported a strong financial performance for the first quarter of the fiscal year ending March 31, 2026, with significant increases in net sales and profits compared to the previous year. The company also included ISK Biosciences India Pvt. Ltd. in its consolidation scope, indicating an expansion in its operational footprint.

More about ISHIHARA SANGYO KAISHA, LTD.

Ishihara Sangyo Kaisha, Ltd. is a company listed on the Tokyo Stock Exchange, primarily involved in the chemical industry. The company focuses on producing and selling chemical products, with a significant presence in the Japanese market.

Average Trading Volume: 197,576

Technical Sentiment Signal: Buy

Current Market Cap: Yen88.7B

Find detailed analytics on 4028 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1